Balyasny Asset Management’s Pactiv Evergreen Inc. Common stock PTVE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-100,919
Closed -$1.82M 3506
2025
Q1
$1.82M Sell
100,919
-168,148
-62% -$2.99M ﹤0.01% 1747
2024
Q4
$4.7M Buy
+269,067
New +$3.64M 0.01% 1317
2023
Q3
Sell
-37,594
Closed -$285K 2823
2023
Q2
$285K Buy
37,594
+25,726
+217% +$196K ﹤0.01% 2002
2023
Q1
$94.9K Buy
+11,868
New +$122K ﹤0.01% 2321
2021
Q2
Sell
-14,634
Closed -$201K 2444
2021
Q1
$201K Buy
+14,634
New +$227K ﹤0.01% 1578

Balyasny Asset Management's PTVE Position: Q2 2025 in Review

Balyasny Asset Management sold out of Pactiv Evergreen Inc. Common stock (PTVE) in Q2 2025, closing a stake of 100,919 shares — an estimated $1.82M sold.

Balyasny Asset Management first reported a position in PTVE in Q1 2021 and held it in 5 quarters. The position peaked at $4.7M in Q4 2024. 0 funds tracked by Wall St. Rank hold PTVE as of Q2 2025.

  • Balyasny Asset Management reported no remaining Pactiv Evergreen Inc. Common stock position as of Q2 2025 after selling out during the quarter.
  • Balyasny Asset Management sold 100,919 Pactiv Evergreen Inc. Common stock shares in Q2 2025, an estimated $1.82M.
  • Balyasny Asset Management first reported a position in Pactiv Evergreen Inc. Common stock in Q1 2021 and held it in 5 quarters.
  • Balyasny Asset Management's Pactiv Evergreen Inc. Common stock position peaked at $4.7M in Q4 2024.
  • 0 funds tracked by Wall St. Rank held Pactiv Evergreen Inc. Common stock as of Q2 2025.

Based on Balyasny Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.